亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

What are the trends in the treatment of multiple sclerosis in recent studies? – A bibliometric analysis with global productivity during 1980–2021

医学 多发性硬化 格拉默 芬戈莫德 主题(文档) 生产力 文献计量学 家庭医学 图书馆学 精神科 计算机科学 宏观经济学 经济
作者
Serdar Aykaç,Sinan Eliaçık
出处
期刊:Multiple sclerosis and related disorders [Elsevier BV]
卷期号:68: 104185-104185 被引量:19
标识
DOI:10.1016/j.msard.2022.104185
摘要

There is no bibliometric analysis in the literature on the subject of the treatment of multiple sclerosis (MS), which is a disease with increasing prevalence, severely affecting the life and quality of life of patients. The purpose of this study was to analyze the scientific articles published on the subject of MS treatment, using bibliometric approaches and statistical methods, and thereby show the trend subjects and global productivity.From 14,443 publications on the subject of MS between 1980 and 2021, 5010 in the category of article were retrieved from the Web of Science and analyzed statistically. Bibliometric network visualization diagrams were created to determine trend subjects, collaborations between countries and citation analyzes. Exponential Smoothing estimation was used to predict the number of articles to be published in the next 5 years. Correlations were determined using Spearman's correlation analysis.The 3 countries contributing the most to literature were found to be the USA (1385, 37.6%), Italy (700, 13.9%), and Germany (694, 13.8%). The most productive author was Hartung Hans-Peter (n = 82) and the most productive institution was the University of London (n = 198). The three most productive journals were the Multiple Sclerosis Journal (n = 354), Multiple Sclerosis and Related Disorders (n = 224), and Neurology (n = 204). The most studied subjects can be listed from past to present as interferon beta, disease-modifying treatment or drugs, relapsing, natalizumab, fingolimod, glatiramer acetate, fatigue, alemtuzumab, cytokines, mitoxantrone, MRI, adherence, depression, experimental autoimmune encephalomyelitis, quality of life, and biomarkers.The scientific production related to MS treatment shows growth chronologically over the years. According to the findings of the analysis done to identify trending subjects, the key words studied in recent years were determined to be fingolimod, alemtuzumab, disease-modifying therapy, ocrelizumab, teriflunomide, rituximab, dimethyl fumarate, safety, biomarkers, COVID-19, oxidative stress, inflammation, vitamin D, relapsing multiple sclerosis, cost-effectiveness, cladribine tablets, and medication adherence. Western countries, especially European countries, the USA, and Canada lead the way in research and scientific collaboration on the subject of MS treatment. These findings can contribute to a better understanding of this subject and can help provide new ideas for further studies.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
4秒前
6秒前
追寻从寒发布了新的文献求助10
9秒前
11秒前
ding的应助被超级小飞侠采纳,获得10
11秒前
12秒前
12秒前
火星仙人掌完成签到 ,获得积分10
13秒前
隐形期待完成签到,获得积分10
14秒前
yinian完成签到,获得积分10
17秒前
终梦的应助被zhang采纳,获得10
17秒前
17秒前
爱静静完成签到,获得积分0
18秒前
19秒前
streetlight发布了新的文献求助10
22秒前
yinian发布了新的文献求助10
23秒前
GQ完成签到 ,获得积分10
23秒前
Ava的应助被ping采纳,获得10
23秒前
在水一方的应助被追寻从寒采纳,获得10
29秒前
y'y'y发布了新的文献求助10
30秒前
30秒前
专注的思松完成签到,获得积分10
33秒前
ABJ完成签到 ,获得积分10
34秒前
洛久竹完成签到 ,获得积分10
36秒前
37秒前
科研通AI6.2的应助被吐司采纳,获得10
38秒前
xx2026发布了新的文献求助10
43秒前
寒冷的凌萱完成签到,获得积分10
44秒前
46秒前
Sp1dey完成签到 ,获得积分10
46秒前
fantasy的应助被xby0328采纳,获得10
47秒前
FIGGIEKIO发布了新的文献求助10
50秒前
翻翻书完成签到,获得积分10
50秒前
碎片发布了新的文献求助10
51秒前
心随以动完成签到 ,获得积分10
53秒前
渡安完成签到 ,获得积分10
53秒前
多情莫言完成签到,获得积分10
54秒前
修辛完成签到 ,获得积分10
58秒前
zzz完成签到,获得积分10
58秒前
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8195004
求助须知:如何正确求助?哪些是违规求助? 9580729
关于积分的说明 21872554
捐赠科研通 7794720
什么是DOI,文献DOI怎么找? 3437836
关于科研通互助平台的介绍 2561159
邀请新用户注册赠送积分活动 2484541